{"id":"fluarix-influsplit-ssw","safety":{"commonSideEffects":[{"rate":"10–40","effect":"Injection site soreness, redness, or swelling"},{"rate":"5–15","effect":"Myalgia (muscle aches)"},{"rate":"5–10","effect":"Headache"},{"rate":"5–10","effect":"Fatigue"},{"rate":"1–5","effect":"Low-grade fever"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"The vaccine contains inactivated (killed) influenza virus antigens from three or four seasonal strains, which trigger both humoral and cellular immune responses. Upon vaccination, the body produces specific antibodies and T-cell responses that provide protection against infection by matching circulating influenza viruses during the flu season.","oneSentence":"Fluarix is an inactivated influenza vaccine that stimulates the immune system to produce antibodies against seasonal influenza virus strains.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T00:46:49.008Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Seasonal influenza prevention in adults and children"}]},"trialDetails":[{"nctId":"NCT01144299","phase":"PHASE3","title":"A Study to Evaluate the Safety and Immunogenicity of GSK Biologicals' Seasonal Influenza Vaccine in Adults","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2010-06-17","conditions":"Influenza","enrollment":114},{"nctId":"NCT00920374","phase":"PHASE3","title":"A Study for Evaluation of Immunogenicity and Reactogenicity of FluarixTM / Influsplit SSW® 2009/2010 in Adults","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2009-06-16","conditions":"Influenza","enrollment":118},{"nctId":"NCT01730378","phase":"PHASE4","title":"Immunogenicity and Safety of PrepandrixTM in Korean Subjects Aged 18 to 60 Years Old","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2012-12-05","conditions":"Influenza","enrollment":131},{"nctId":"NCT00706563","phase":"PHASE3","title":"A Study for Evaluation of Immunogenicity and Reactogenicity of Fluarix™ / Influsplit SSW® 2008/2009 in Adults","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2008-07-07","conditions":"Influenza","enrollment":120},{"nctId":"NCT00476307","phase":"PHASE3","title":"Immunogenicity and Reactogenicity of Fluarix™ (Influsplit SSW®) 2007/2008 in People 18 Years Old or Above","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2007-06","conditions":"Influenza","enrollment":120},{"nctId":"NCT01160237","phase":"PHASE3","title":"Study to Evaluate the Immune Response and the Safety of Fluarix TM/ Influsplit SSW® 2010/2011 or Pandemrix TM","status":"TERMINATED","sponsor":"GlaxoSmithKline","startDate":"2010-08","conditions":"Influenza","enrollment":7},{"nctId":"NCT00345904","phase":"PHASE3","title":"Study to Evaluate the Safety and Immunogenicity of Fluarix™ 2006/2007 in Adults Aged 18 Years or Above","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2006-07","conditions":"Influenza","enrollment":120},{"nctId":"NCT00731393","phase":"PHASE3","title":"Immuno & Reacto of TF Trivalent Influenza Split Vaccine 2003/04 or of Std Formulation Influsplit SSW®/Fluarix™ 2003/04","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2003-10","conditions":"Influenza","enrollment":157},{"nctId":"NCT00731029","phase":"PHASE3","title":"Reacto & Immunogenicity of TF Formulation of Influsplit SSW® 2002/03 v/s Std Formulation of Influsplit SSW® 2002/03","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2002-09","conditions":"Influenza","enrollment":239}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":1,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_3","status":"active","brandName":"Fluarix™/Influsplit SSW®","genericName":"Fluarix™/Influsplit SSW®","companyName":"GlaxoSmithKline","companyId":"gsk","modality":"Biologic","firstApprovalDate":"","aiSummary":"Fluarix is an inactivated influenza vaccine that stimulates the immune system to produce antibodies against seasonal influenza virus strains. Used for Seasonal influenza prevention in adults and children.","enrichmentLevel":3,"visitCount":1,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}